Envestnet Asset Management’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-27,841
Closed -$54.8K 4032
2023
Q2
$54.8K Sell
27,841
-15,027
-35% -$28.8K ﹤0.01% 3866
2023
Q1
$37K Sell
42,868
-14,579
-25% -$36.5K ﹤0.01% 3882
2022
Q4
$121K Buy
57,447
+11,928
+26% +$27K ﹤0.01% 3781
2022
Q3
$104K Buy
45,519
+24,580
+117% +$74.5K ﹤0.01% 3727
2022
Q2
$59K Buy
20,939
+438
+2% +$1.54K ﹤0.01% 3806
2022
Q1
$93K Buy
20,501
+3,305
+19% +$18.2K ﹤0.01% 3810
2021
Q4
$140K Buy
+17,196
New +$169K ﹤0.01% 3722
2021
Q3
Sell
-63,766
Closed -$986K 3678
2021
Q2
$986K Sell
63,766
-11,830
-16% -$199K ﹤0.01% 2529
2021
Q1
$1.53M Buy
75,596
+2,373
+3% +$58.7K ﹤0.01% 2111
2020
Q4
$1.98M Buy
73,223
+6,846
+10% +$154K ﹤0.01% 1762
2020
Q3
$1.23M Sell
66,377
-791
-1% -$14K ﹤0.01% 1899
2020
Q2
$1.2M Buy
67,168
+5,078
+8% +$77.3K ﹤0.01% 1861
2020
Q1
$571K Buy
62,090
+2,010
+3% +$30K ﹤0.01% 2147
2019
Q4
$1.03M Buy
60,080
+9,852
+20% +$132K ﹤0.01% 2006
2019
Q3
$522K Buy
50,228
+9,088
+22% +$122K ﹤0.01% 2342
2019
Q2
$642K Sell
41,140
-100
-0.2% -$1.78K ﹤0.01% 2232
2019
Q1
$756K Buy
41,240
+12,229
+42% +$217K ﹤0.01% 2066
2018
Q4
$483K Buy
+29,011
New +$673K ﹤0.01% 2175
2018
Q3
Sell
-13
Closed 1483
2018
Q2
$0 Hold
13
﹤0.01% 2859
2018
Q1
$0 Hold
13
﹤0.01% 2855
2017
Q4
$0 Buy
+13
New +$354 ﹤0.01% 2965
2017
Q3
Sell
-13
Closed 2928
2017
Q2
$0 Sell
13
-8
-38% -$191 ﹤0.01% 3056
2017
Q1
$0 Buy
21
+8
+62% +$168 ﹤0.01% 3118
2016
Q4
$0 Buy
+13
New +$240 ﹤0.01% 3120

Other funds holding CLLS

Envestnet Asset Management's CLLS Position: Q3 2023 in Review

Envestnet Asset Management sold out of Cellectis (CLLS) in Q3 2023, closing a stake of 27,841 shares — an estimated $54.8K sold.

Envestnet Asset Management first reported a position in CLLS in Q4 2016 and held it in 24 quarters. The position peaked at $1.98M in Q4 2020. 31 funds tracked by Wall St. Rank hold CLLS as of Q3 2023.

  • Envestnet Asset Management reported no remaining Cellectis position as of Q3 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 27,841 Cellectis shares in Q3 2023, an estimated $54.8K.
  • Envestnet Asset Management first reported a position in Cellectis in Q4 2016 and held it in 24 quarters.
  • Envestnet Asset Management's Cellectis position peaked at $1.98M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Cellectis as of Q3 2023.

Based on Envestnet Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.